Browse by Journal Title

2009

New approaches to pathogenesis and management of hypertension.
Ritz, E. and Krum, H. and Schlaich, M. and Whitbourn, R. and Sobotka, P.A. and Sadowski, J. and Bartus, K. and Kapelak, B. and Walton, A. and Sievert, H. and Thambar, S. and Abraham, W.T. and Esler, M. and Wang, Y. and Tsun, Z. and Machnik, A. and Neuhofer, W. and Jantsch, J. and Dahlmann, A. and Tammela, T. and Machura, K. and Park, J.K. and Beck, F.X. and Mueller, D.N. and Derer, W. and Goss, J. and Ziomber, A. and Dietsch, P. and Wagner, H. and van Rooijen, N. and Kurtz, A. and Hilgers, K.F. and Alitalo, K. and Eckardt, K.U. and Luft, F.C. and Kerjaschki, D. and Titze, J.
Clinical Journal of the American Society of Nephrology 4 (12): 1886-1891. December 2009

More mixed messages in terms of salt.
Luft, F.C.
Clinical Journal of the American Society of Nephrology 4 (11): 1699-1700. November 2009

2007

Niacin lowers serum phosphate and increases HDL cholesterol in dialysis patients.
Mueller, D. and Mehling, H. and Otto, B. and Bergmann-Lips, R. and Luft, F.C. and Jordan, J. and Kettritz, R.
Clinical Journal of the American Society of Nephrology 2 (6): 1249-1254. November 2007

Vasopressin, urine concentration, and hypertension: a new perspective on an old story.
Luft, F.C.
Clinical Journal of the American Society of Nephrology 2 (2): 196-197. March 2007

2006

Direct renin inhibition with aliskiren in hypertension and target organ damage.
Mueller, D.N. and Luft, F.C.
Clinical Journal of the American Society of Nephrology 1 (2): 221-228. March 2006